Havens Advisors Llc Buys Wright Medical Group NV, The Medicines Co, Ra Pharmaceuticals Inc, Sells Celgene Corp, Spark Therapeutics Inc, Genesee & Wyoming Inc

• New Purchases: WMGI, MDCO, RARX, TIF, AXE, ARQL, QGEN, ACHN, BOLD, AMTD, TSG, KEM, AKS, FIT, JAG, TIVO,
• Added Positions: WBC, AGN, ADSW, TGE, WCG,
• Reduced Positions: MLNX, PACB, CZR, S,
• Sold Out: CELG, ONCE, GWR, MDSO, VSM, GHDX, CRZO, AXTA, ALDR, CVRS, GCI, PACQ, FOXA,

For the details of HAVENS ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/havens+advisors+llc/current-portfolio/portfolio

1. Allergan PLC (AGN) - 71,500 shares, 12.60% of the total portfolio. Shares added by 22.22%
2. WellCare Health Plans Inc (WCG) - 41,300 shares, 12.57% of the total portfolio. Shares added by 11.62%
3. Advanced Disposal Services Inc (ADSW) - 312,500 shares, 9.47% of the total portfolio. Shares added by 28.60%
4. Wright Medical Group NV (WMGI) - 287,800 shares, 8.09% of the total portfolio. New Position
5. Cypress Semiconductor Corp (CY) - 311,000 shares, 6.69% of the total portfolio.

Havens Advisors Llc initiated holding in Wright Medical Group NV. The purchase prices were between $19.41 and $30.59, with an estimated average price of $26.4. The stock is now traded at around $30.20. The impact to a portfolio due to this purchase was 8.09%. The holding were 287,800 shares as of .

Havens Advisors Llc initiated holding in The Medicines Co. The purchase prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this purchase was 6.11%. The holding were 78,000 shares as of .

Havens Advisors Llc initiated holding in Ra Pharmaceuticals Inc. The purchase prices were between $22.62 and $47.35, with an estimated average price of $44.57. The stock is now traded at around $47.15. The impact to a portfolio due to this purchase was 5.02%. The holding were 116,000 shares as of .

Havens Advisors Llc initiated holding in Tiffany & Co. The purchase prices were between $86.63 and $133.8, with an estimated average price of $119.09. The stock is now traded at around $134.07. The impact to a portfolio due to this purchase was 3.19%. The holding were 25,900 shares as of .

Havens Advisors Llc initiated holding in Anixter International Inc. The purchase prices were between $66.46 and $92.97, with an estimated average price of $81.43. The stock is now traded at around $98.63. The impact to a portfolio due to this purchase was 2.8%. The holding were 33,000 shares as of .

Havens Advisors Llc initiated holding in Arqule Inc. The purchase prices were between $7.49 and $20.39, with an estimated average price of $11.77. The stock is now traded at around $20.00. The impact to a portfolio due to this purchase was 2.73%. The holding were 148,500 shares as of .

Havens Advisors Llc added to a holding in WABCO Holdings Inc by 182.70%. The purchase prices were between $134.18 and $135.52, with an estimated average price of $134.85. The stock is now traded at around $135.83. The impact to a portfolio due to this purchase was 2.62%. The holding were 32,510 shares as of .

Havens Advisors Llc added to a holding in Allergan PLC by 22.22%. The purchase prices were between $165.4 and $191.58, with an estimated average price of $180.86. The stock is now traded at around $189.69. The impact to a portfolio due to this purchase was 2.29%. The holding were 71,500 shares as of .

Havens Advisors Llc added to a holding in Advanced Disposal Services Inc by 28.60%. The purchase prices were between $32.61 and $32.98, with an estimated average price of $32.8. The stock is now traded at around $33.00. The impact to a portfolio due to this purchase was 2.11%. The holding were 312,500 shares as of .

Havens Advisors Llc added to a holding in Tallgrass Energy LP by 69.38%. The purchase prices were between $17.71 and $22.14, with an estimated average price of $19.2. The stock is now traded at around $22.32. The impact to a portfolio due to this purchase was 1.64%. The holding were 196,100 shares as of .

Havens Advisors Llc sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.

Havens Advisors Llc sold out a holding in Spark Therapeutics Inc. The sale prices were between $96.25 and $113.57, with an estimated average price of $107.51.

Havens Advisors Llc sold out a holding in Genesee & Wyoming Inc. The sale prices were between $110.16 and $111.94, with an estimated average price of $111.13.

Havens Advisors Llc sold out a holding in Medidata Solutions Inc. The sale prices were between $91.48 and $92.24, with an estimated average price of $91.87.

Havens Advisors Llc sold out a holding in Versum Materials Inc. The sale prices were between $52.97 and $52.99, with an estimated average price of $52.98.

Havens Advisors Llc sold out a holding in Genomic Health Inc. The sale prices were between $63.44 and $71.32, with an estimated average price of $67.76.